Whereas in T2DM patients GIP no longer stimulates insulin secretion GLP-1, at pharmacological concentrations, can still acutely, and glucose-dependently potentiate insulin secretion [17], [18]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.